Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Its become a coveted luxury in middle- and low-income countries, with high prices being the main barrier to usage the cost is $95 a month in Brazil and $115 in South Africa, compared with about $350 in the US
Individuals focused on athletic performance or fat metabolism may benefit from slightly higher amounts under proper guidance
Suitability considerations: Consistent with class precedents for GLP-1-based therapies, retatrutide would not be expected to be suitable during pregnancy or breastfeeding, and paediatric data are currently lacking
For complete documentation checklists and PA preparation: Wegovy Prior Authorization Guide YOUR PLAN COVERS IT If Your PA Was Denied If Your PA Was Denied Your plan covers Wegovy, but the prior authorization was rejected
With known benefits on metabolic health and possible direct effects on vascular function, GLP-1 agonists could help manage walking limitations in patients with PAD
